CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 263 filers reported holding CYTOKINETICS INC in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $597,743 | -9.7% | 20,290 | -0.0% | 0.01% | 0.0% |
| Q2 2023 | $662,023 | +119614.8% | 20,295 | +29.2% | 0.01% | +25.0% |
| Q1 2023 | $553 | -23.4% | 15,705 | -0.4% | 0.00% | -33.3% |
| Q4 2022 | $722 | -99.9% | 15,765 | -0.6% | 0.01% | 0.0% |
| Q3 2022 | $755,000 | +22.4% | 15,865 | +1.0% | 0.01% | +20.0% |
| Q2 2022 | $617,000 | +37.4% | 15,710 | +28.7% | 0.01% | +66.7% |
| Q1 2022 | $449,000 | -8.6% | 12,210 | -17.5% | 0.00% | -25.0% |
| Q4 2021 | $491,000 | +8.1% | 14,795 | +16.5% | 0.00% | +33.3% |
| Q3 2021 | $454,000 | +116.2% | 12,700 | +19.6% | 0.00% | +200.0% |
| Q2 2021 | $210,000 | -15.0% | 10,620 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $247,000 | +38.0% | 10,620 | +23.5% | 0.00% | +100.0% |
| Q4 2020 | $179,000 | -16.7% | 8,600 | -13.6% | 0.00% | -50.0% |
| Q3 2020 | $215,000 | +16.8% | 9,950 | +27.6% | 0.00% | 0.0% |
| Q2 2020 | $184,000 | +109.1% | 7,800 | +4.0% | 0.00% | +100.0% |
| Q1 2020 | $88,000 | +10.0% | 7,500 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $80,000 | – | 7,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,989,218 | $47,348,000 | 10.09% |
| EcoR1 Capital, LLC | 2,139,697 | $20,306,000 | 8.01% |
| Healthcare Value Capital, LLC | 100,000 | $949,000 | 1.15% |
| DAFNA Capital Management LLC | 150,000 | $1,424,000 | 1.13% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 151,106 | $1,434,000 | 1.07% |
| Avoro Capital Advisors LLC | 503,900 | $4,782,000 | 1.06% |
| ACUTA CAPITAL PARTNERS, LLC | 140,969 | $1,338,000 | 0.64% |
| Iguana Healthcare Management, LLC | 150,000 | $1,424,000 | 0.58% |
| WASATCH ADVISORS LP | 1,746,096 | $16,570,000 | 0.25% |
| Virtus ETF Advisers LLC | 29,379 | $279,000 | 0.21% |